| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 86581 |
1610950-41-8,DOTA-MeTz,DOTA-甲基四嗪 |
105 |
kx |
2024-11-22 |
| 86582 |
p-NCS-benzyl-DOTA p-NCS-苄基-DOTA |
151 |
zcy |
2024-11-22 |
| 86583 |
1189194-64-6,DOTA-(COOt-Bu)3-CH2-Alkynyl |
87 |
kx |
2024-11-22 |
| 86584 |
DOTA-cyclo(RGDfK);DOTA-RGD |
102 |
wyh |
2024-11-22 |
| 86585 |
CuAAC修饰的DOTAZA 齐岳定制 |
124 |
zcy |
2024-11-22 |
| 86586 |
1039726-31-2,DOTA-JR-11 |
88 |
kx |
2024-11-22 |
| 86587 |
zher2-HSA-DOTA DOTA螯合剂偶联ZHER2支架多肽缀合人血清白蛋白 |
133 |
zcy |
2024-11-22 |
| 86588 |
CAS:1800229-46-2 Maleimide-DOTA-GA |
100 |
zyl |
2024-11-22 |
| 86589 |
panitumumab-DOTA DOTA标记的抗EGFR帕尼单抗 |
101 |
zcy |
2024-11-22 |
| 86590 |
DOTA-CH2-Ph-azide(HCl salt) |
97 |
kx |
2024-11-22 |
| 86591 |
DOTA-三(酸) - 酰氨基-DPEG(R)11-马来酰亚胺 |
114 |
zyl |
2024-11-22 |
| 86592 |
DOTA-Glu「cyclo(Arg-Gly-Asp-D-Phe-Lys)」2 |
102 |
kx |
2024-11-22 |
| 86593 |
CAS:834870-39-2 DOTA series |
111 |
zyl |
2024-11-22 |
| 86594 |
DOTA-cyclo(RGDfK);DOTA-RGD |
104 |
wyh |
2024-11-22 |
| 86595 |
DOTA-PEG-SH、DOTA-PEG-Thiol的结构组成 |
101 |
kx |
2024-11-22 |
| 86596 |
DTPA-bis anhydride,二亚乙基三胺五乙酸二酐 |
113 |
wyh |
2024-11-22 |
| 86597 |
NOTA-PEG5000-Mal ;NOTA PEG5 马来酰亚胺 |
83 |
wyh |
2024-11-22 |
| 86598 |
DOTA-E「c(RGDfK)2」 |
93 |
kx |
2024-11-22 |
| 86599 |
DOTA-L-Lys(SA。Pam)-PSMA-617 DOTA偶联二膦酸盐和PSMA抑制剂 |
108 |
zcy |
2024-11-22 |
| 86600 |
DOTA-E[c(RGDfK)2]的应用领域 |
116 |
kx |
2024-11-22 |
| 86601 |
DOTA-氟喹诺酮衍生物 DOTA-fluoroquinolone derivatives |
91 |
zcy |
2024-11-22 |
| 86602 |
DOTA-NHS |
159 |
kx |
2024-11-22 |
| 86603 |
p-SCN-Bn-DTPA,102650-30-6,1-(4-异硫氰酸酯)二乙炔三胺 |
96 |
wyh |
2024-11-22 |
| 86604 |
NOTA-PEG-RGD |
92 |
kx |
2024-11-22 |
| 86605 |
三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸;137076-54-1 |
125 |
wyh |
2024-11-22 |
| 86606 |
DOTA-PEG-CRGD的结构组成、应用领域 |
89 |
kx |
2024-11-22 |
| 86607 |
DOTA-MWCNT-Gd DOTA钆配合物修饰多壁碳纳米管 |
93 |
zcy |
2024-11-22 |
| 86608 |
817562-90-6,(R)-tert-Bu4-DOTAGA,(R)-DOTAGA-四叔丁酯 |
85 |
kx |
2024-11-22 |
| 86609 |
DOTA-四聚乙二醇-甲基四嗪 |
105 |
zyl |
2024-11-22 |
| 86610 |
DOTA-奥曲肽,DOTA-octreotide |
121 |
kx |
2024-11-22 |
| 86611 |
DOTA-五聚乙二醇-C4-二苯并环辛炔 |
77 |
zyl |
2024-11-22 |
| 86612 |
127985-74-4 ,p-SCN-Bn-DOTA |
107 |
kx |
2024-11-22 |
| 86613 |
DOTA-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2,250612-06-7 |
88 |
wyh |
2024-11-22 |
| 86614 |
DOTA探针分子DOTA-EM7 |
90 |
kx |
2024-11-22 |
| 86615 |
DOTA-四聚乙二醇-二苯并环辛炔;DSPE-PEG4-DBCO |
96 |
wyh |
2024-11-22 |
| 86616 |
DOTA缀合RAWVAWR-NH2 DOTA-RAWVAWR-NH2 |
96 |
zcy |
2024-11-22 |
| 86617 |
DOTA-FYLEHPSGGLAV-OH |
86 |
kx |
2024-11-22 |
| 86618 |
Fmoc-L-Lys-mono-amide-DOTA-tris(t-Bu ester),479081-06-6 |
81 |
wyh |
2024-11-22 |
| 86619 |
锕系元素(ⅲ)-DOTA配合物 Actinide(III)-DOTA Complexes |
99 |
zcy |
2024-11-22 |
| 86620 |
DOTA-PEG8-NHCO-MeTz |
86 |
zyl |
2024-11-22 |
| 86621 |
909024-55-1,DOTA-cyclo(RGDfK) acetate |
93 |
kx |
2024-11-22 |
| 86622 |
DOTA生物素肌氨酸;DOTA-Biotin-Sarcosine |
75 |
wyh |
2024-11-22 |
| 86623 |
环烯配体DOTA衍生物AspDOTA、GlyDOTA和PropDOTA |
140 |
zcy |
2024-11-22 |
| 86624 |
Eu-DOTA-氮氧化合物 Eu-DOTA-NOx |
102 |
zcy |
2024-11-22 |
| 86625 |
DOTATATE |
111 |
kx |
2024-11-22 |